BU CTSI Symposium Honors David Seldin, MD

The Boston University Clinical and Translational Science Institute hosted its fifth annual research symposium March 28 in Metcalf Hall on the Charles River Campus.

The robust program included eight guest speakers, a video presentation and a poster session.  The event honored David C. Seldin, MD, PhD, a founding member of the BU CTSI, whose contributions and presence in the BU Medical community will live on through the many colleagues who paid tribute to his career.

Medical Campus Provost and BUSM Dean Karen H. Antman, MD, and Wade Professor and Chair of the Department of Medicine, David L. Coleman, MD, each spoke of Seldin’s important contributions and wisdom, and presented his family with a crystal plaque to commemorate the event.  Seldin was a Professor of Medicine and Microbiology at BUSM, Director of the Amyloidosis Center, and Chief of the Section of Hematology-Oncology at Boston Medical Center.

More than 175 guests attended the symposium that featured former colleagues of Seldin, who shared memories of their friend and spoke about their work, which was centered primarily on the topic of Amyloidosis.  The morning session concluded with a video presentation and tribute from George Murphy, PhD, who was unable to attend to honor his mentor.

The symposium also included three keynote presentations.  Jeffrey W. Kelly, PhD, of The Scripps Research Institute spoke about “Adapting the Chemistry and Biology of Proteostasis to Ameliorate Degenerative Diseases;” Ann C. McKee, MD, and Robert A. Stern, PhD, from BU’s Alzheimer’s Disease and CTE Center, presented “Chronic Traumatic Encephalopathy:  What We Know Now and What We Need to Learn Next.” 

A broad range of translational science topics were represented by 57 ePoster board presentations. The lively session resulted in four posters earning a top score and a $1,000 prize.   A list of abstracts and winners can be found here.